2021
DOI: 10.24038/mgyf.2021.063
|View full text |Cite
|
Sign up to set email alerts
|

Conocimiento, reconocimiento e investigación colaborativa para el 2022 centrado en al covid-19 persistente

Abstract: Documento colaborativo entre colectivos de pacientes y sociedades científicas Versión 1.0. Fecha: 01/05/2021 Este documento será sometido a actualizaciones periódicas en función del avance del estado del conocimiento.

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
3

Citation Types

0
3
0

Year Published

2023
2023
2023
2023

Publication Types

Select...
1

Relationship

0
1

Authors

Journals

citations
Cited by 1 publication
(3 citation statements)
references
References 62 publications
(98 reference statements)
0
3
0
Order By: Relevance
“…Numerous terms have been used to refer to this new entity ( Chaichana et al, 2023 ); the most accepted terms are persistent COVID and long COVID ( Lopez-Leon et al, 2021 ; Mandal et al, 2021 ; Abrignani et al, 2022 ; Sugiyama et al, 2022 ), and a large number of organisations have attempted to provide a validated definition that is accepted by the scientific community. The multiple definitions that have emerged, since the appearance of the first cases, consider it as a multi-organ disease that affects those patients that have suffered from COVID-19, with persistent symptoms and fluctuating frequency, and without an alternative underlying illness that can explain such symptoms ( Abrignani et al, 2022 ; Rubin, 2020 ; SemFYC: Manifestaciones Persistentes de la Covid-19, 2020 ; Siegelman, 2020 ; Severe Acute Respiratory Syndrome, 2021 ; Shah et al, 2021 ; Yang et al, 2021 ; Rodriguez-Sanchez et al, 2022 ; Centers for Disease Control, 2022 ; Rodriguez Ledo, 2021 ).…”
Section: Introductionmentioning
confidence: 99%
See 2 more Smart Citations
“…Numerous terms have been used to refer to this new entity ( Chaichana et al, 2023 ); the most accepted terms are persistent COVID and long COVID ( Lopez-Leon et al, 2021 ; Mandal et al, 2021 ; Abrignani et al, 2022 ; Sugiyama et al, 2022 ), and a large number of organisations have attempted to provide a validated definition that is accepted by the scientific community. The multiple definitions that have emerged, since the appearance of the first cases, consider it as a multi-organ disease that affects those patients that have suffered from COVID-19, with persistent symptoms and fluctuating frequency, and without an alternative underlying illness that can explain such symptoms ( Abrignani et al, 2022 ; Rubin, 2020 ; SemFYC: Manifestaciones Persistentes de la Covid-19, 2020 ; Siegelman, 2020 ; Severe Acute Respiratory Syndrome, 2021 ; Shah et al, 2021 ; Yang et al, 2021 ; Rodriguez-Sanchez et al, 2022 ; Centers for Disease Control, 2022 ; Rodriguez Ledo, 2021 ).…”
Section: Introductionmentioning
confidence: 99%
“…In Spain, it is estimated that at least 10% of people infected present symptoms that can be attributed to this affectation. ( Rodriguez Ledo, 2021 ) Therefore, assuming the most favourable prevalences, persistent COVID still affects millions of people in the world.…”
Section: Introductionmentioning
confidence: 99%
See 1 more Smart Citation